Clinical Trials Logo
  1. Home
  2. Acute Mesenteric Ischemia
  3. NCT06212921
  4. Details
NCT06212921 Clinical Trial

Biomarkers in Prediction of AMI

Acute Mesenteric Ischemia Clinical Trial

— BIPAMI  

Official title:
Biomarkers In Prediction of Acute Mesenteric Ischaemia: a Prospective Multicentre Study (BIPAMI Study)

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT06212921
Other study ID # BIPAMI study
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date October 2024
Est. completion date September 2025

Study information
Verified date January 2024
Source University of Tartu
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 250
Est. completion date September 2025
Est. primary completion date September 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age 18 years or older - Initial decision in favour of further diagnostics of mesenteric ischaemia Exclusion Criteria: - Age <18 years - Consent declined by patient or next of kin (delayed consent) - Chronic mesenteric ischaemia without an acute event - Immediate decision for withdrawal of further diagnostics and active treatment - Referral from another hospital with already established diagnosis of AMI - AMI diagnosed at surgery without previously having been considered

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• Sequential blood samples
Sequential blood samples for diagnostic tests is the only intervention in thei study

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
University of Tartu

Outcome
Type Measure Description Time frame Safety issue
Primary Rate of correctly predicted cases of acute mesenteric ischaemia Rate of correctly predicted cases of Acute mesenteric ischaemia using different biomarkers 10 months
See also
  Status Clinical Trial Phase
Recruiting NCT05194527 - The Detrimental Course of Acute Intestinal Ischemia
Not yet recruiting NCT06387147 - ORal Antibiotics In Acute Mesenteric Ischemia Phase 3
Completed NCT04867499 - Epidemiology of Acute Mesenteric Ischemia
Recruiting NCT03518099 - Searching Biomarkers of Acute Intestinal Ischemic Injuries N/A
Active, not recruiting NCT06365827 - Perioperatively Assessed Biomarker I-FABP Level for Prediction of Acute Mesenteric Ischemia and Its Correlation With Acute Kidney Injury, Followed by Extracorporeal Circulation (aMIKI)
Completed NCT05218863 - Incidence, Diagnosis, Management and Outcome of Acute Mesenteric Ischemia
Completed NCT05706012 - Antithrombotic Management of Acute Mesenteric Ischaemia
Not yet recruiting NCT06310395 - Analysis of the Acute Mesenteric Ischemia in a Single Institution Over 10 Years
Completed NCT05665946 - Acute Intestinal Necrosis- the Preoperative Diagnostic Approach
Recruiting NCT01788904 - Plasma i-FABP as Predictor for Irreversible Bowel Ischemia N/A
Recruiting NCT02772913 - Mesenteric Ischemia in the Emergency Department: a Retrospective Multicenter Study N/A